Snowball logo
logo
NSIS

Novozymes A/S Class B

DKK 417.40+DKK 1.30Β  (0.31%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
2,001316.82,397.63,830.54,154.54,200.9
COGS
844.9143.91,095.32,022.41,914.61,918.7
Gross Profit
155.2172.81,302.31,808.12,239.82,282.2
Operating Expenses & Income
Operating Income
536.383.54609.7658.5881.9875.7
Total Operating Expenses
634.189.3692.61,149.61,357.91,406.5
R&D Expenses
268.936.11270.2412.9463.4477.6
Selling General & Admin Expenses
11517.18128.5214.4223224.7
Earnings from Continuing Operations
Interest Expense
(13.65)(21.25)(29.87)(87.55)(80.47)(69.87)
Interest Income
2.4091172.42040112.0626.921-
Income Tax Expense
104.315.7116.6111.2159.7159
Net Income
Net Income
421.166.34405.1305.6583.2596.9
Supplemental
EBIT
538.884.06546.8493.1811.1(153.4)
EBITDA
722.7110.4732.81,036.81,385.51,497.1
In millions of DKK, except % and values per 1 share